Cargando…

New directions in incidence and prevalence of diagnosed diabetes in the USA

OBJECTIVE: To determine whether diabetes prevalence and incidence has remained flat or changed direction during the past 5 years. RESEARCH DESIGN AND METHODS: We calculated annual prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined) for civilian, non-institutionalized adults a...

Descripción completa

Detalles Bibliográficos
Autores principales: Benoit, Stephen R, Hora, Israel, Albright, Ann L, Gregg, Edward W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557467/
https://www.ncbi.nlm.nih.gov/pubmed/31245008
http://dx.doi.org/10.1136/bmjdrc-2019-000657
_version_ 1783425451952177152
author Benoit, Stephen R
Hora, Israel
Albright, Ann L
Gregg, Edward W
author_facet Benoit, Stephen R
Hora, Israel
Albright, Ann L
Gregg, Edward W
author_sort Benoit, Stephen R
collection PubMed
description OBJECTIVE: To determine whether diabetes prevalence and incidence has remained flat or changed direction during the past 5 years. RESEARCH DESIGN AND METHODS: We calculated annual prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined) for civilian, non-institutionalized adults aged 18–79 years using annual, nationally representative cross-sectional survey data from the National Health Interview Survey from 1980 to 2017. Trends in rates by age group, sex, race/ethnicity, and education were calculated using annual percentage change (APC). RESULTS: Overall, the prevalence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.4%) from 1990 to 2009 to a peak of 8.2 per 100 adults (95% CI 7.8 to 8.6), and then plateaued through 2017. The incidence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.8%) from 1990 to 2007 to 7.8 per 1000 adults (95% CI 6.7 to 9.0), and then decreased significantly (APC −3.1%) to 6.0 (95% CI 4.9 to 7.3) in 2017. The decrease in incidence appears to be driven by non-Hispanic whites with an APC of −5.1% (p=0.002) after 2008. CONCLUSIONS: After an almost 20-year increase in the national prevalence and incidence of diagnosed diabetes, an 8-year period of stable prevalence and a decrease in incidence has occurred. Causes of the plateauing and decrease are unclear but the overall burden of diabetes remains high and deserves continued monitoring and intervention.
format Online
Article
Text
id pubmed-6557467
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65574672019-06-26 New directions in incidence and prevalence of diagnosed diabetes in the USA Benoit, Stephen R Hora, Israel Albright, Ann L Gregg, Edward W BMJ Open Diabetes Res Care Epidemiology/Health Services Research OBJECTIVE: To determine whether diabetes prevalence and incidence has remained flat or changed direction during the past 5 years. RESEARCH DESIGN AND METHODS: We calculated annual prevalence and incidence of diagnosed diabetes (type 1 and type 2 combined) for civilian, non-institutionalized adults aged 18–79 years using annual, nationally representative cross-sectional survey data from the National Health Interview Survey from 1980 to 2017. Trends in rates by age group, sex, race/ethnicity, and education were calculated using annual percentage change (APC). RESULTS: Overall, the prevalence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.4%) from 1990 to 2009 to a peak of 8.2 per 100 adults (95% CI 7.8 to 8.6), and then plateaued through 2017. The incidence of age-adjusted, diagnosed diabetes did not change significantly from 1980 to 1990, but increased significantly (APC 4.8%) from 1990 to 2007 to 7.8 per 1000 adults (95% CI 6.7 to 9.0), and then decreased significantly (APC −3.1%) to 6.0 (95% CI 4.9 to 7.3) in 2017. The decrease in incidence appears to be driven by non-Hispanic whites with an APC of −5.1% (p=0.002) after 2008. CONCLUSIONS: After an almost 20-year increase in the national prevalence and incidence of diagnosed diabetes, an 8-year period of stable prevalence and a decrease in incidence has occurred. Causes of the plateauing and decrease are unclear but the overall burden of diabetes remains high and deserves continued monitoring and intervention. BMJ Publishing Group 2019-05-28 /pmc/articles/PMC6557467/ /pubmed/31245008 http://dx.doi.org/10.1136/bmjdrc-2019-000657 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology/Health Services Research
Benoit, Stephen R
Hora, Israel
Albright, Ann L
Gregg, Edward W
New directions in incidence and prevalence of diagnosed diabetes in the USA
title New directions in incidence and prevalence of diagnosed diabetes in the USA
title_full New directions in incidence and prevalence of diagnosed diabetes in the USA
title_fullStr New directions in incidence and prevalence of diagnosed diabetes in the USA
title_full_unstemmed New directions in incidence and prevalence of diagnosed diabetes in the USA
title_short New directions in incidence and prevalence of diagnosed diabetes in the USA
title_sort new directions in incidence and prevalence of diagnosed diabetes in the usa
topic Epidemiology/Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557467/
https://www.ncbi.nlm.nih.gov/pubmed/31245008
http://dx.doi.org/10.1136/bmjdrc-2019-000657
work_keys_str_mv AT benoitstephenr newdirectionsinincidenceandprevalenceofdiagnoseddiabetesintheusa
AT horaisrael newdirectionsinincidenceandprevalenceofdiagnoseddiabetesintheusa
AT albrightannl newdirectionsinincidenceandprevalenceofdiagnoseddiabetesintheusa
AT greggedwardw newdirectionsinincidenceandprevalenceofdiagnoseddiabetesintheusa